AMANDA SNYDER: Open Payments
NPI 1053819136 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 10 payments from 6 companies in 2025. Trend: 2023 $214 · 2024 $245 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $257 |
| Axsome Therapeutics, Inc. | 2 | $244 |
| Teva Pharmaceuticals USA, Inc. | 2 | $146 |
| Janssen Pharmaceuticals, Inc | 1 | $126 |
| Novo Nordisk Inc | 1 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: ABILIFY MAINTENA, Auvelity, INVEGA SUSTENNA, UZEDY, Rivfloza, AUSTEDO XR, CAPLYTA, REXULTI.
Industry payments across OH — which companies pay providers there.
